These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17707960)

  • 21. Medical eligibility, comprehension of the consent process, and retention of injection drug users recruited for an HIV vaccine trial.
    Harrison K; Vlahov D; Jones K; Charron K; Clements ML
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):386-90. PubMed ID: 7552502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV prevention for injecting drug users: the first 25 years and counting.
    Des Jarlais DC; Semaan S
    Psychosom Med; 2008 Jun; 70(5):606-11. PubMed ID: 18519886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of full-length glycoprotein 120 from incident HIV type 1 subtype E and B infections in Bangkok injecting drug users with prototype E and B strains that are components of a candidate vaccine.
    Phan KO; Callahan ME; Vanichseni S; Hu DJ; Raktham S; Young N; Choopanya K; Mastro TD; Subbarao S
    AIDS Res Hum Retroviruses; 2000 Sep; 16(14):1445-50. PubMed ID: 11018864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A sudden epidemic of HIV type 1 among injecting drug users in the former Soviet Union: identification of subtype A, subtype B, and novel gagA/envB recombinants.
    Bobkov A; Kazennova E; Selimova L; Bobkova M; Khanina T; Ladnaya N; Kravchenko A; Pokrovsky V; Cheingsong-Popov R; Weber J
    AIDS Res Hum Retroviruses; 1998 May; 14(8):669-76. PubMed ID: 9618078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An HIV vaccine--challenges and prospects.
    Johnston MI; Fauci AS
    N Engl J Med; 2008 Aug; 359(9):888-90. PubMed ID: 18753644
    [No Abstract]   [Full Text] [Related]  

  • 26. [Epidemic situation on human immunodeficiency virus in Russian Federation in 2009].
    Goliusov AT; Dement'eva LA
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (6):31-4. PubMed ID: 21381374
    [No Abstract]   [Full Text] [Related]  

  • 27. Grim news for vaccine.
    AIDS Patient Care STDS; 2002 Oct; 16(10):513-4. PubMed ID: 12442739
    [No Abstract]   [Full Text] [Related]  

  • 28. Preparations for AIDS vaccine trials. Incident human immunodeficiency virus (HIV) infections in a cohort of injection drug users in Baltimore, Maryland.
    Nelson KE; Vlahov D; Galai N; Astemborski J; Solomon L
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S201-5. PubMed ID: 7865301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 'Mosaic' HIV vaccine to be tested in thousands of people across the world.
    Mega ER
    Nature; 2019 Aug; 572(7768):165-166. PubMed ID: 31388154
    [No Abstract]   [Full Text] [Related]  

  • 30. Street policing, injecting drug use and harm reduction in a Russian city: a qualitative study of police perspectives.
    Rhodes T; Platt L; Sarang A; Vlasov A; Mikhailova L; Monaghan G
    J Urban Health; 2006 Sep; 83(5):911-25. PubMed ID: 16855880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002.
    Tovanabutra S; Beyrer C; Sakkhachornphop S; Razak MH; Ramos GL; Vongchak T; Rungruengthanakit K; Saokhieo P; Tejafong K; Kim B; De Souza M; Robb ML; Birx DL; Jittiwutikarn J; Suriyanon V; Celentano DD; McCutchan FE
    AIDS Res Hum Retroviruses; 2004 May; 20(5):465-75. PubMed ID: 15186520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A success story: HIV prevention for injection drug users in Rhode Island.
    Beckwith CG; Moreira CC; Aboshady HM; Zaller N; Rich JD; Flanigan TP
    Subst Abuse Treat Prev Policy; 2006 Dec; 1():34. PubMed ID: 17144920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Willingness of Chinese injection drug users to participate in HIV vaccine trials.
    Yin L; Zhang Y; Qian HZ; Rui B; Zhang L; Zhu J; Guan Y; Wang Y; Li Q; Ruan Y; Shao Y
    Vaccine; 2008 Feb; 26(6):762-8. PubMed ID: 18191881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug injecting and syringe use in the HIV risk environment of Russian penitentiary institutions: Qualitative study.
    Sarang A; Rhodes T; Platt L; Kirzhanova V; Shelkovnikova O; Volnov V; Blagovo D; Rylkov A
    Addiction; 2006 Dec; 101(12):1787-96. PubMed ID: 17156178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Injecting drugs of abuse and immunity: implications for HIV vaccine testing and efficacy.
    Ugen KE; Nyland SB
    Springer Semin Immunopathol; 2006 Nov; 28(3):281-7. PubMed ID: 17109182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV/AIDS in Russia: determinants of regional prevalence.
    Moran D; Jordaan JA
    Int J Health Geogr; 2007 Jun; 6():22. PubMed ID: 17553136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling HIV vaccines in Brazil: assessing the impact of a future HIV vaccine on reducing new infections, mortality and number of people receiving ARV.
    Fonseca MG; Forsythe S; Menezes A; Vuthoori S; Possas C; Veloso VG; Lucena Fde F; Stover J
    PLoS One; 2010 Jul; 5(7):e11736. PubMed ID: 20668523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of HIV/AIDS among injecting drug users in Russia: opportunities and barriers to scaling-up of harm reduction programmes.
    Tkatchenko-Schmidt E; Renton A; Gevorgyan R; Davydenko L; Atun R
    Health Policy; 2008 Feb; 85(2):162-71. PubMed ID: 17767974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Broadening inclusion of vulnerable populations in HIV vaccine trials.
    Lau CY; Cardinali M; Sato PA; Fix A; Flores J
    Expert Rev Vaccines; 2008 Mar; 7(2):259-68. PubMed ID: 18324894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Forecasting the future of HIV epidemics: the impact of antiretroviral therapies & imperfect vaccines.
    Blower S; Schwartz EJ; Mills J
    AIDS Rev; 2003; 5(2):113-25. PubMed ID: 12876900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.